Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021

Paul Choi Initiated (SWTX) at Strong Buy and Held Target at $112 on, Mar 22nd, 2021

Paul Choi of Goldman Sachs, Initiated "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy and Held Target at $112 on, Mar 22nd, 2021.

Paul has made no other calls on SWTX in the last 4 months.



There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $124 on, Thursday, February 25th, 2021